In what situations would immunotherapy alone be appropriate for non-metastatic NSCLC?

Based on our current SOC treatment paradigms for patients who don't have contraindications to definitive treatment options, my short answer would be no. However, few caveats to that no as always. Few examples where I think this would be an appropriate approach based on currently available data.

1. Poor...